SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001571049-14-001847
Filing Date
2014-05-14
Accepted
2014-05-14 17:14:20
Documents
5
Group Members
DANIEL J. DONOGHUEDISCOVERY EQUITY PARTNERS, L.P.MICHAEL R. MURPHY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D t79323_sc13d.htm SC 13D 153723
2 EXHIBIT 1 ex-1.htm EX-1 96544
3 EXHIBIT 2 ex-2.htm EX-2 10400
4 EXHIBIT 3 ex-3.htm EX-3 10037
5 EXHIBIT 4 ex-4.htm EX-4 10021
  Complete submission text file 0001571049-14-001847.txt   282255
Mailing Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606
Business Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606 (312) 265-96000
Discovery Group I, LLC (Filed by) CIK: 0001312548 (see all company filings)

IRS No.: 300075077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Subject) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-86843 | Film No.: 14842511
SIC: 2834 Pharmaceutical Preparations